How to Target the Right Physicians Using Trigger Programs
As therapies become increasingly complex and personalized, it is imperative that physicians...
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL). While PPRL remains essential for de-identified data exchange, the study presented during our recent webinar shows that certain token-based approaches...
As therapies become increasingly complex and personalized, it is imperative that physicians...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
Today’s most innovative companies are leveraging digital health data solutions to deliver...
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
Lab Data in Clinical Research: 4 Ways It Drives Better Outcomes While most life sciences teams know...
Diabetes is a complex disease that affects over 37 million Americans, or 11% of the population, and...
As we honor our military service members this Veterans Day, we take time to reflect on how we can...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world evidence...